The Life Science Industries have been going through dynamic changes during the last decade. This trend is expected to continue unabatedly.

Todays life science industry is a unique mix of start-ups and established companies from small sizes to multinational players. The near, medium and long term growth potential among the industry is far from being exploited on a worldwide basis. BioAlliance is poised to help its clients to globally develop the emerging life science sector unlike anyone else in the industry.

Large and diversified companies with both life sciences and other business interests have re-focused their strategies to exploit the growth potential of this sector.

The formation of start-ups, besides the large companies, is growing at an ever increasing pace. Aggressive funding, coupled with top science, people, and execution are critical components of future successful biotech companies.

Recognizing the importance of this new sector, many countries have chosen life sciences to be their next strategic focus of economic development and have placed it on their various national agendas. This includes many EU countries, such as France and Germany, as well as the Asian/Pacific region with e.g. China, Japan, Singapore and Taiwan.

As a result of these activities there is an ever growing need for new life science start-ups to develop their business on a global scale and find synergies and partnerships which are so crucial to their growth and survival.

BioAlliance AG was founded to provide solutions in order to meet those needs and aspires to be instrumental in the growth and developmental process of young life science companies. BioAlliance's long term objective is to build a well structured network of start-up companies together with life science entrepreneurs